CRISTYNA OTTAIANO: Open Payments
NPI 1841979150 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$999 in 53 payments from 10 companies in 2025. Trend: 2023 $299 · 2024 $551 · 2025 $999
Food & beverage: $999
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $243 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $175 |
| Amgen Inc. | 10 | $168 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $109 |
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| PFIZER INC. | 3 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Boston Scientific Corporation | 1 | $22 |
Products named: LEQVIO, LifeVest, REPATHA, ELIQUIS, JARDIANCE, Kerendia, CAMZYOS, VERQUVO.
Industry payments across FL — which companies pay providers there.
